Mattias Ivarsson is committed to fighting a nasty bacterium at the root of many hospital-acquired infections. This article describes the story behind Inositec’s technology and CEO.
10th November 2014
Categories
Most Recent
- Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer
- Inositec wins Swiss Technology Award 2017
- Inositec featured in BioCentury
- Interview of Inositec CEO by Scrip Intelligence
- Inositec AG Secures CHF1.4 million in Seed Financing to Advance New Class of Inositol Hexaphosphate-Based Drug Candidates
Du nouveau contre le Clostridium difficile
Swiss national radio interviews Mattias Ivarsson about Inositec’s therapeutic approach to treat Clostridium difficile infection (in French).
6th November 2014
Posted in News
Leave a comment
ETH doctoral student wins Zurich’s Falling Walls Lab
Inositec’s CEO wins the jury and audience prize at the Falling Walls Lab in Zurich and is invited to attend the Falling Walls Lab Final, Conference and Circle in Berlin!
24th September 2014
Posted in News
Leave a comment
Von Darm, Charme und einer Mauer
Tages Anzeiger describes the Falling Walls Lab Zurich 2014 and features Mattias Ivarsson (in German).
24th September 2014
Posted in News
Leave a comment
Toxine statt Bakterien bekämpfen
This article provides an accessible description of our therapeutic approach (in German).
23rd July 2012
Posted in News
Leave a comment